Shots: The US FDA has granted BTD to the tebentafusp (IMCgp100) for the treatment of HLA-A*02:01-positive adult patients with unresectable/ mUM The pre-planned interim analysis of a P-III study (IMCgp100-202) […]readmore
Tags : Tebentafusp